dynamics cannot be dictated by neuronal activity through a linear relationship. Instead, we advance a theory that microglial dynamics follow a 'Ushape' model of dynamics in response to neuronal activity via noradrenergic signaling.
results
Microglial process surveillance increases after general anesthesia. Microglial processes extend and retract to survey the brain parenchyma. We first investigated how microglial process dynam ics behave in the awake state using heterozygous mice expressing green fluorescent protein (GFP) under the control of the fractalkine receptor (Cx3cr1 GFP/+ mice) to visualize microglia in the somato sensory cortex ( Supplementary Fig. 1a-d ). After recovery from cranial window surgery (2-4 weeks), mice were trained to freely move on a custommade, rotating treadmill while head restrained ( Supplementary Fig. 1a ). Using in vivo twophoton imaging, we observed that microglial processes maintain a relatively stable terri tory of surveillance in awake animals ( Supplementary Fig. 1e-g) .
We initially hypothesized that microglial process surveillance is dependent on neuronal activity, and would therefore be attenuated by general anesthesia. However, when isoflurane (1.2% in oxygen, 700 ml min -1 ) was applied to the animal via a nose cone, we surpris ingly observed that microglial processes began to extend and occupy a greater area of brain parenchyma, herein termed process surveil lance ( Fig. 1a,b ; Supplementary Video 1). Increased process sur veillance was initiated a few minutes after isoflurane induction and reached peak levels after 20-30 min. As expected, neuronal network activity in the cortex was strongly suppressed immediately after iso flurane induction, as determined by dampened calcium spikes in GCaMP6sexpressing cortical neurons ( Fig. 1a,b ; Supplementary  Fig. 2a-d ; Supplementary Video 2) and by in vivo electrophysiology showing slow wave activity ( Supplementary Fig. 2e ,f). We found that 10 min of isoflurane administration was sufficient to initiate an increase in microglial process surveillance that persisted for at least 50 min after isoflurane cessation ( Supplementary Fig. 3 ). Thus, increases in microglial process surveillance represent a delayed but persistent response to the suppression of cortical network activ ity. Accompanying their increased process surveillance, microglia also exhibited faster process movement velocity ( Fig. 1c ) and more intricate ramified morphology, as demonstrated by a Sholl analysis and measurements of process lengths and number of branch points ( Fig. 1e-g) . These results reveal that isoflurane anesthesia enhances rather than inhibits microglial process dynamics.
Among other targets, isoflurane can inhibit the microglial two pore domain potassium channel THIK1, which controls micro glial process ramification and surveillance 21 . Our results, however, showed that isoflurane increased rather than decreased microglial process surveillance. Therefore, to determine whether the micro glial process surveillance changes were unique to isoflurane admin istration or represent a broader microglial response to general anesthesia, we also investigated the effects of two other commonly used anesthetics: ketamine/xylazine and urethane. Similar to isoflu rane inhalation, systemic administration (intraperitoneal) of either ketamine/xylazine (87.5 mg per kg ketamine and 12.5 mg per kg xylazine) or urethane (1.6 g per kg) increased microglial process surveillance ( Fig. 1h,i) . Thus, multiple classes of general anesthetics can enhance microglial process surveillance relative to the awake state. Our results suggest that the awake condition may represent a constrained state of microglia in surveying the brain parenchyma.
To further delineate the potential function of microglial process surveillance, we assessed two events: (1) microglial process chemo taxis toward laser injury and (2) microglial process interaction with neuronal dendrites. We found that the velocity of microglial process chemotaxis in response to laser burn was significantly higher under anesthesia than in the awake condition ( Supplementary Fig. 4a ). Next, we used Cx3cr1 GFP/+ :Thy1-YFP mice to examine microglial process interaction with neuronal dendrites in vivo. We found that microglial processes displayed longer contact duration and a larger contact area with dendrites under anesthesia compared to the awake condition ( Supplementary Fig. 4b,c ). These latter results suggest that increased microglial process surveillance could be translated into enhanced microglia-neuron interaction under anesthesia.
Whisker trimming increases microglial process surveillance in awake mice. Suppressed neuronal activity precedes the increase in microglial process surveillance under general anesthesia, which suggests that neuronal activity might negatively regulate microglial process dynamics. However, general anesthesia also alters metabo lism, blood pressure and cardiac output 22 . For these reasons, we additionally employed unilateral whisker trimming as an approach to reduce neuronal activity and to study microglial process dynam ics 23 . Whisker trimming is a sensorydeprivation method that suppresses neuronal activity in the contralateral barrel cortex, as demonstrated by calcium imaging in GCaMP6sexpressing cortical neurons ( Supplementary Fig. 5a -c; Supplementary Video 3). In response to whisker trimming, microglia in the contralateral bar rel cortex began to increase their process area and survey a greater territory of the barrel cortex, similarly to responses we observed for general anesthesia ( Fig. 2a,b ; Supplementary Video 4). Moreover, the latency for microglia to increase their surveillance after whis ker trimming had a similar delayedonset time course compared to anesthesia ( Supplementary Fig. 5d ,e). Sensory deprivation only increased process surveillance in microglia of the contralateral barrel cortex, with no effect observed for microglia of the ipsilateral barrel cortex ( Fig. 2c,d ). Therefore, these results demonstrate that reductions in regionspecific sensory input selectively and nega tively regulate microglial process surveillance.
Our whisker trimming experiments further substantiate the observation that reduced neuronal activity enhances microglial process surveillance. To determine whether sensory deprivation and general anesthesia increase microglial process surveillance through unique or shared mechanisms, we determined whether their combi nation had an additive effect on microglial surveillance. To this end, we performed unilateral whisker trimming followed by isoflurane inhalation after an additional 30 min. We found that whisker trim ming increased microglial process surveillance, but the addition of isoflurane anesthesia did not further increase process surveillance ( Fig. 2e ,f). Thus, whisker trimming and isoflurane anesthesia do not have additive effects on microglial process surveillance, which suggests that they may share a similar mechanism for triggering an increase in microglial process dynamics.
Both pharmacological and optogenetic inhibition of neuronal network activity increase microglial process surveillance in awake mice. Results from the general anesthesia and sensorydepri vation paradigms indicate that neuronal activity regulates microg lial process dynamics. To directly test this idea, we manipulated cortical network activity through pharmacological and optogenetic approaches and then examined microglial process surveillance. We used an intracerebral catheter and applied a potent and selective agonist for GABA A receptors, muscimol (870 µM, 10 µl), to suppress neuronal network activity in the somatosensory cortex ( Fig. 3a) . Indeed, we found that muscimol application in awake mice reduced neuronal calcium activity in the somatosensory cortex ( Supplementary Fig. 6 ; Supplementary Video 5). Coincident with the reduction in neuronal calcium activity, microglia increased their process surveillance ( Fig. 3a ,c; Supplementary Video 6). By contrast, intracerebral application of artificial cerebrospinal fluid (ACSF) did not alter microglial process surveillance (Fig. 3b ). Similarly, we found that microglial surveillance increased after intracerebral application of TTX (10 µM) to inhibit neuronal firing in the awake animal ( Supplementary Fig. 7 ). Thus, pharmacological inhibition of local neuronal network activity in the cortex is able to recapitu late the changes in microglial process dynamics induced by general anesthesia or whisker trimming.
Next, we employed an optogenetic strategy to suppress neuronal activity. Channelrhodopsin 2 (ChR2) was expressed in VGAT positive GABAergic neuron populations using VGATChR2 trans genic mice. Optogenetic activation of GABAergic cell populations in this transgenic line has previously been shown to suppress neuronal network activity 24 . Proper ChR2 expression and func tion in VGATpositive interneurons was confirmed in our experi ments by wholecell patchclamp recording in acute brain slices ( Fig. 4a,b ; Supplementary Fig. 8a,b ). We found that in awake mice, activation of VGATChR2 by 470nm blue light (10 Hz, 10 min) increased microglial process surveillance ( Fig. 4c,d ; Supplementary Video 7; Fig. 8c,d ). Building on findings obtained from the gen eral anesthesia experiments ( Supplementary Fig. 3 ), transient and reversible network inhibition via optogenetic methods triggered a prolonged increase in microglial surveillance that was sustained for at least 20 min ( Supplementary Fig. 8c,d ). Together, these results demonstrate that inhibition of local cortical network activity by pharmacological or optogenetic means can trigger an increase in microglial process surveillance in awake mice. NE signaling regulates microglial process surveillance in awake mice. Next, we investigated the molecular mechanisms underlying the observed increase in microglial process surveillance following neuronal activity suppression. To date, the ATP/ADPsensing P2Y 12 receptor has been shown to regulate microglial process extension in a variety of contexts 14, 20, 25 . To test whether P2Y 12 receptor signaling mediates the observed increase in microglial process surveillance, we imaged process surveillance in P2Y 12 receptordeficient mice (Cx3cr1 GFP/+ :P2y12 −/− ). Surprisingly, we found that in P2y12 −/− mice, isoflurane anesthesia still increased microglial process surveil lance ( Fig. 5a,b ). Therefore, unlike injury or hyperactivityinduced microglial process extension 20, 26 , the observed increase in microglial surveillance following isoflurane is not regulated by P2Y 12 signal ing. Fractalkine signaling and its receptor CX 3 CR1 are reported to promote microglial process dynamics and microglia-neuron inter actions 27 . Therefore, we used Cx3cr1 −/− (Cx3cr1 GFP/GFP ) mice to test whether CX 3 CR1 contributes to the increased anesthesiainduced microglial surveillance. We found that isoflurane anesthesia in Cx3cr1 −/− mice similarly increased microglial process surveillance ( Fig. 5c,d ), which suggests that fractalkine signaling is not involved in increasing microglial surveillance following anesthesia. Previous studies have found that primary neurotransmitters such as glutamate and GABA cannot directly induce microglial process chemotaxis 20, 28 . For these reasons, we focused instead on investigating whether the neurotransmitters acetylcholine, dopa mine, NE and serotonin affected microglial process dynamics. These neurotransmitters were specifically studied because their activity is significantly decreased by general anesthesia 29 . We intracerebrally applied each neurotransmitter during isoflurane inhalation ( Fig. 5e ). Interestingly, we found that NE (3 mM, 10 μl) application, but not acetylcholine (5 mM, 10 μl), dopamine (1 mM, 10 μl) or serotonin (5 mM, 10 μl), prevented the increase in micro glial process surveillance induced by isoflurane anesthesia (Fig. 5f ). These results suggest that reduced NE signaling in the anesthetized condition selectively increases microglial process surveillance.
We further studied the regulation of microglial process surveil lance by NE during whisker trimming and optogenetic inhibition trimming increases microglial process surveillance in the barrel cortex of awake mice. a, Microglial morphology in the contralateral barrel cortex before (0 min) and 30 min after whisker trimming in awake mice. b, Microglial process area and surveillance territory increases after trimming the contralateral whiskers (area: P = 0.0079, t(8) = 3.512; territory: P = 0.0001, t(8) = 8.152). c, Microglial morphology in the ipsilateral barrel cortex before (0 min) and 30 min after whisker trimming in awake mice. d, No changes in microglial process area and surveillance territory are observed after trimming the ipsilateral whiskers (area: P = 0.5439, t(8) = 0.63337; territory: P = 0.5086, t(8) = 0.6919). e, Experimental paradigm: microglial process dynamics were studied in the awake mouse at baseline before trimming the contralateral whiskers 20 min later. Isoflurane was then introduced 30 min after whisker trimming. f, Microglial process area and surveillance increases in the contralateral barrel cortex following trimming, but do not show an additional increase when isoflurane is later administered (area: whisker trimming versus baseline, P < 0.0001, t(8) = 7.34; +isoflurane versus baseline, P < 0.0001, t(8) = 9.153; whisker trimming versus +isoflurane, P = 0.624, t(8) = 0.5097; territory: whisker trimming versus baseline, P = 0.0004, t(8) = 5.89; +isoflurane versus baseline, P = 0.0002, t(8) = 6.639; whisker trimming versus +isoflurane, P = 0.2184, t(8) = 1.336). N = 9 cells per 3 mice for each group; NS, not significant, **P ≤ 0.01, ***P ≤ 0.001, paired t-test (two-tailed). For a and c, experiments were repeated three times independently with similar results obtained.
( Fig. 6 ). Intracerebral NE administration, but not ACSF adminis tration, prevented the increase in microglial process surveillance induced by contralateral whisker trimming ( Fig. 6a-c) . Intracerebral NE administration also prevented the increase in microglial process surveillance induced by optogenetic inhibition (Fig. 6d-f ). β 2 -adrenergic receptors control microglial process surveillance in awake mice. Microglia are known to express high levels of β 2 adrenergic receptors 30 . Their activation induces microglial process retraction in brain slices 31 . Using RNAscope in situ hybridization, we indeed found that most IBA1positive microglia (97.6%) colocalized with β 2 adrenergic receptor (Adrb2) mRNA ( Supplementary Fig. 9 ). To explore whether adrenergic receptors control microglial process activity in awake mice, we examined the effects of βadrenergic receptor antagonists on microglial dynamics ( Fig. 7a-c ). Interestingly, both propranolol (300 μM, 10 μl; Fig. 7b ), a highaffinity anatagonist of β 1 and β 2 receptors, and the highly selective β 2 receptor antagonist ICI 118,551 (30 μM, 10 μl; Fig. 7c ) induced an increase in microglial process surveillance in awake mice. In addition, an intracerebral injection of TTX (50 µM) fol lowed by application of ICI 118,551 (10 µM) 30 min later did not further increase microglial surveillance ( Supplementary Fig. 7 ). Thus, inhibition of β 2 adrenergic receptors can increase microglial process dynamics. Cortical NE tone is largely generated by noradrenergic neurons in the LC 32 , which project into the somatosensory cortex ( Fig. 7d ; Supplementary Video 8). Microglial processes are in close proxi mity to noradrenergic axons, as shown by labeling with adenoassociated viruses (AAVs; a combination of AAV.rTH.Cre and AAV.FLEX. tdTomato; Fig. 7d ). To directly study the effect of NE signaling on microglia, we used a chemogenetic approach to selectively sup press noradrenergic neurons in the LC by activating GiDREADD, which decreases cAMP levels and generally reduces neuronal firing rates. A GiDREADDloxPflanked mouse (R26LSLGi DREADD) was bred with the Cx3cr1 GFP/+ line. Expression of the GiDREADD receptor was confined to the LC through a targeted AAVCre injection (AAV9.rTH.PI.Cre.SV40) ( Fig. 7e ). In awake mice, the systemic application of the DREADD ligand clozapine Noxide (CNO; 5 mg per kg, intraperitoneally) increased microglial process surveillance in the somatosensory cortex in GiDREADD expressing mice but not in their control littermates ( Fig. 7f-h ). We confirmed that CNO reduced the firing rate of GiDREADD expressing noradrenergic neurons in the LC using acute brain slices ( Supplementary Fig. 10a-d ). In addition, to test potential offtarget effects of CNO, we applied CNO in anesthetized GiDREADD mice and examined microglial process dynamics. We found that CNO did not further increase microglial surveillance in the anesthetized state ( Supplementary Fig. 10e ). Therefore, our results suggest that CNO targets GiDREADD to reduce endogenous NE release and subsequently increase microglial process surveillance.
To better access and mechanistically study the LC-cortex circuitry, we performed several experiments in acute cortical slices. In slices, noradrenergic projections were well preserved ( Supplementary Fig. 11a ), but their connections to noradrenergic somata were severed during slice preparation (see Methods). Unlike the in vivo context (Supplementary Video 2), neuronal network activity was weak in cortical slices ( Supplementary Fig. 11b ,c; Supplementary Video 9). Bath application of a moderate dose of glutamate (50 µM) increased neuronal activity in cortical slices ( Supplementary Fig. 11b ,c; Supplementary Video 9), which resulted in reduced microglial surveillance ( Fig. 8a) . We further found that the β 2 adrenergic receptor antagonist ICI 118,551 (10 µM) blocked the glutamateinduced decreases in microglial surveillance ( Fig. 8b) . Next, to test the direct effect of NE on microglial dynamics in cortical brain slices, we applied exogenous NE or chemogenetically induced endogenous NE release. Indeed, exogenous application of NE (30 μM) inhibited microglial process surveillance in cortical slices; this effect was abolished by ICI 118,551 (10 µM) (Fig. 8c ). The application of ICI 118,551 (10 μM) alone did not affect microg lial process surveillance, presumably due to the low activity of NEreleasing axons in brain slices (Fig. 8c ). In slices prepared from mice with viralinduced expression of GqDREADD in LC adrener gic neurons and their projections, CNO was confirmed to increase neuronal firing ( Fig. 8d,e ). In addition, activation of noradrenergic terminals by CNO reduced microglial process surveillance ( Fig. 8f ). Therefore, our results suggest that local neuronal activity affects NE signaling, which is sufficient to regulate microglial process surveil lance, even in the absence of LC somata.
Together, both β 2 adrenergic receptor antagonism and che mogenetic inhibition of NE release can increase microglial pro cess surveillance in awake mice. Inhibiting NE signaling therefore mirrors the effects of general anesthesia, sensory deprivation and optogenetic inhibition on microglial process surveillance. Overall, our results demonstrate that reduced NE signaling establishes a permissive microenvironment for enhanced microglial process sur veillance. Meanwhile, tonic NE levels in the awake animal repress process surveillance and maintain a highly constrained microglial surveying state ( Supplementary Fig. 12 ). 
Discussion
Microglia are the immune surveilling cells of the brain that shape neuronal circuitry in both health and disease 6 . Multiple studies have demonstrated that the interactions between microglial pro cesses and neuronal elements play a critical role in maintaining brain homeostasis 9, 18 . However, microglial process dynamics in vivo have been studied predominantly under anesthesia. Moreover, it is unclear whether neuronal network activity under awake conditions drive distinct microglial dynamics. Here, using in vivo imaging in awake mice, we showed that general anesthesia, sensory deprivation and optogenetic inhibition of local neuronal activity dramatically increases microglial process surveillance. We also pinpointed the underlying mechanism involved in the increased process surveil lance, which arises from a reduction in NE signaling to microglial β 2 adrenergic receptors. These results demonstrate that neuronal network activity inhibits microglial process dynamics through tonic NE signaling in awake mice.
Neuronal activity dictates microglial process dynamics. Prior studies of microglial imaging under anesthesia and of brain slices found that microglial process dynamics seem to follow neuronal activity patterns. Increased neuronal activity after bicuculline appli cation, a GABA A receptor antagonist, enhances microglial pro cess sampling 13 . In addition, neuronal hyperactivity triggered by NMDA receptor activation induces microglial process extension toward neuronal cell bodies and dendrites 20, 26 . Consistently, acute seizures increase microglial process dynamics and process conver gence toward neuronal elements 20 . During neuronal hyperactivity (for example, under seizure conditions), microglia can sense ATP release via the P2Y 12 receptor and extend and converge their process toward an ATP source 20, 26 . We expected that microglia in the awake animal would display more pronounced motility. Surprisingly, we found opposite results, showing that microglia exhibit less process surveillance in the awake condition than under general anesthesia. Consistently, intro ducing sensory deprivation or increased GABAergic network inhi bition in awake animals resulted in similar increases in microglial process dynamics. Supporting this novel observation, a recent study reported that monocular deprivation induced greater microglial process ramification in the contralateral visual cortex 33 . Together, our results reveal that neuronal activity negatively regulates micro glial surveillance in awake mice. Therefore, in awake mice, micro glial process dynamics are kept in a relatively constrained state.
Our results, in combination with previous studies that used general anesthesia, suggest that microglial process dynamics are not linearly dependent on neuronal activity (that is, increasing neuronal activity increases microglial process dynamics). Rather, microglial dynamics follows a Ushaped curve of regulation; that is, either increasing or decreasing neuronal activity relative to the awake state can increase microglial process dynamics. While microglial extension and convergence during hyperactivity or acute injury has been demonstrated through an ADP/ATP and P2Y 12 receptor dependent mechanism, we show here that a reduction in NE tone and β 2 adrenergic activation (due to suppressed neuronal activity) results in microglial extension and territory surveillance. Although our results ruled out the contribution of P2Y 12 receptor signaling in the increased territory surveillance, other studies have demon strated that microglial P12Y 12 and β 2 adrenergic receptors control microglial process motility in vitro through interacting mecha nisms 31 . Overall, our study demonstrates that microglial dynam ics are highly attuned to changes in the local microenvironment, but follow a Ushape style of regulation rather than linear activity dependent regulation.
Tonic NE and microglial process dynamics. Here, we demon strated that tonic NE signaling selectively regulates microglial pro cess surveillance in vivo, which is based on several lines of evidence. First, of the four potential neuromodulators tested (acetylcholine, dopamine, NE and serotonin), only NE prevented anesthesia induced microglial process extension. Second, exogenous NE also prevented the increase in microglial process surveillance induced by whisker trimming and optogenetic inhibition. Finally, pharma cological inhibition of microglial β 2 adrenergic receptors and chemogenetic inhibition of LC noradrenergic neurons increased microglial process surveillance in awake mice. LC noradrenergic neurons are the exclusive source of NE in the cortex 34 . Indeed, we showed that there are abundant LC projections in the somato sensory cortex, consistent with the reported ~1.2 million axon varicosities per LC neuron 35 . Additionally, a wealth of adrenergic receptors are expressed in neurons and glia 36 . Among them, the β 2 adrenergic receptor is highly enriched in microglia compared with other cell types 30 . Previous studies have also shown that microglial β 2 adrenergic receptors are critical for microglial motility, migra tion, phagocytosis, proliferation and inflammatory responses 36 .
Our study corroborates the importance of noradrenergic regulation of microglia function by providing evidence that tonic NE inhib its microglial process surveillance via β 2 adrenergic receptors in awake mice. While microglia represent an enriched cell population for func tional β 2 adrenergic receptor expression 30 , the downstream signal ing cascades that mediate β 2 receptordependent process motility and surveillance are still undefined in microglia. It is known that the β 2 adrenergic receptor is coupled to Gs protein signaling. Thus, inhibition of microglial β 2 receptors should reduce cyclic AMP production, based on canonical Gs signaling 37 . Similarly, the Gicoupled P2Y 12 receptor, which also alters cAMP levels, induces microglial process chemotaxis, while the Gscoupled A 2A receptor mediates microglial process retraction 38 . Therefore, it seems that the intracellular cAMP level is important in regulating microglial process surveillance. Indeed, a very recent study demonstrated that .109) infusion in awake mice trigger an increase in microglial process area and territory surveillance. d, Left: to determine the extent of noradrenergic innervation in the somatosensory cortex by LC neurons, td-Tomato expression was induced selectively in LC neurons using a specific Cre recombination strategy in Cx3cr1 GFP/+ mice. Right: the fluorescent micrograph shows heavy noradrenergic innervation of the somatosensory cortex by LC projections. e, Experimental paradigm: the DREADD receptor agonist CNO was administered (intraperitoneally) to Gi-DREADD mice and control sibling littermates. f, Representative image of microglial morphology before (0 min) and 30 min after CNO administration in a Gi-DREADD mouse. g,h, CNO administration in control mice (g) does not alter microglial process area or territory surveillance (area: P = 0.1193, t(8) = 1.744; territory: P = 0.1326, t(8) = 1.674), while CNO administration in Gi-DREADD mice (h) increases microglial process area and territory surveillance (area: P = 0.0001, t(8) = 6.815; territory: P = 0.0005, t(8) = 5.67). N = 9 cells per 3 mice for each group; ***P ≤ 0.001, paired t-test (two-tailed). For d and f, experiments were repeated three times independently with similar results obtained. cAMP controls microglial filopodia dynamics 39 . However, future studies of whether and how cAMP levels drive microglial process surveillance in vivo are still needed.
Our findings strike an interesting contrast to recent work inves tigating the impact of halogenated anesthetics, such as isoflurane, on microglial process dynamics. Tonic activation of the microglial twopore domain channel THIK1 was recently shown to control microglial process ramification and surveillance 21 . THIK1 inhibi tion via isoflurane reduces microglial process surveillance in hip pocampal slices. In contrast, our study indicates that isoflurane increases microglial process dynamics in the cortex of awake mice. This discrepancy could be due to microglial heterogeneity within different brain regions (hippocampus versus cortex), but could also be explained by the expected attenuation of NE tone that occurs when LC projections are severed during brain slice preparation. In brain slices, microglial surveillance is likely to be elevated in the absence of a strong NE tone. Potentially, when microglia are relieved of the dynamic constraints set by NE tone in slices, they are disposed to greater modulation in the microenvironment. In vivo, it is possible that the effects of isoflurane on NE tone serve as a stronger impetus for altering microglial dynamics than the effects of isoflurane on THIK1 signaling. However, studies directly assessing β 2 adrenergic and THIK1 receptor signaling on microglial process surveillance will be necessary to clearly understand the conditions and constraints for their functions.
Functional significance of microglial process dynamics regulated by NE tone.
Increased microglial process surveillance broadly suggests that there are more interactions between microglia and features of the brain parenchyma, such as neurons and vascula ture 7, 40, 41 . The functional significance of microglial process interac tion with neurons is an emerging field of research. Previous studies have indicated that microglial interaction may dampen neuronal hyperactivity 20, 42 , while other studies have shown that microglial processes increase dendritic spine Ca 2+ activity 12 and promote new spine formation during brain development and learning 7, 11 . Therefore, microglial process surveillance may play a beneficial role in finetuning neuronal activity by reducing neuronal activity dur ing seizures 19, 20 or by increasing neuronal synchronization during periods of reduced network activity 12 . Calibrating neuronal activ ity occurs in response to divergent neuromodulatory signals that exist in various brain states. While distinct receptors (that is, P2Y 12 and β 2 ) for these divergent neuromodulators have been identified in microglia, many more receptors are likely to exist and may aid in uniquely tuning microglial responses to the environment 3 . Toward this end, emerging tools for studying intracellular signaling mecha nisms, such as cAMP levels, in vivo may greatly advance our ability to understand the complex downstream signaling mechanisms that mediate microglial responses to the microenvironment. LC noradrenergic neurons innervate almost every region of the brain and could therefore have a widespread, potentially uniform, impact on microglial function. Under physiological conditions, NE regulates the sleep-wake cycle in addition to its role in memory and cognition 34 . The loss of LC neurons is an early hallmark of neuro degeneration, as evident in Alzheimer's disease and Parkinson's disease 43 . Meanwhile, chronic stress increases LC neuronal firing rates and brain NE concentrations 44 . Therefore, the relative loss or gain in NE tone under these different pathophysiological contexts could serve as a powerful upstream modulator of microglial func tion across numerous brain regions. In turn, corresponding changes in microglial surveillance could produce profound consequences for the neuronal network over time in chronic conditions, based on the described roles for microglia in tuning neuronal activity. In addition, NE has been shown to reduce proinflammatory gene expression in microglia in various neurological disorders, includ ing stroke, pain and neurodegeneration 36 . In particular, NE can help resolve pathology in mouse models of Alzheimer's disease by promoting microglial phagocytosis of amyloidβ and reducing amyloidβtriggered inflammation 45, 46 . However, microglia are also reported to be inappropriately activated in Alzheimer's disease and mediate early synapse loss 47 . Apart from disease contexts, NE tone is reduced on a daily basis during sleep 48 . It would be interesting to know whether reduced NE tone during sleep may 'disinhibit' microglial motility to allow greater synaptic remodeling to occur during sleep cycles, which might have implications for the consoli dation phase of learning and memory. However, we acknowledge that anesthesia and sleep are not mechanistically identical 49 , and microglial dynamics during sleep will need to be explored in greater detail in future studies. Additionally, even with training, headfixed animals can still remain stressed, thus potentially exaggerating the levels of NE in the awake state. Therefore, for normal animals that are awake but not headfixed, microglial surveillance could be more pronounced than we report here. Nevertheless, future studies are warranted to test the specific role of microglial adrenergic receptor signaling in sleep, memory and neurodegeneration.
In summary, we provide novel insights into microglial process dynamics under awake conditions and their regulation by neuro nal activity and NE tone. Our results demonstrate that microglial process dynamics are fundamentally different in awake animals, emphasizing the importance of studying microglia in awake mice to establish the clearest picture for their basal physiology.
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Methods
Animals. Male and female mice, 2-3 months of age, were used in accordance with institutional guidelines. All experiments were approved by the Mayo Clinic Animal Care and Use Committee. Heterozygous Cx3cr1 GFP/+ were used for all experiments 50 . P2y12 −/− mice were originally donated by M. Dailey at the University of Iowa. The following mice were purchased from the Jackson Laboratory: heterozygous R26LSLGiDREADD (GiDREADD; 026219); transgenic VGAT ChR2 (014548); and R26LSLtdTomato reporter mice (tdTomato; 007909). Heterozygous GiDREADD mice were bred to homozygous Cx3cr1 GFP/GFP mice to obtain GiDREADDpositive and negative (sibling control) offspring for experiments. Transgenic VGATChR2 mice were also bred to homozygous Cx3cr1 GFP/GFP mice to obtain offspring with (TG) and without (nonTG control) transgene expression. Finally, P2y12 −/− mice were bred to P2y12 −/− :Cx3cr1 GFP/GFP mice to obtain P2y12 −/− :Cx3cr1 GFP/+ animals for imaging studies. Thy1YFP mice (Jackson Laboratory, 003782) were bred to Cx3cr1 GFP/GFP to obtain Cx3cr1 GFP/+ : Thy1YFP to observe physical interactions between microglial processes and neuronal dendrites. Animals used for all experiments were randomly selected.
Virus injection.
To image neuronal network activity in vivo, 0.3 µl of AAV9. CamKII.GCaMP6s (G12289, Penn Vector Core) was injected into the somatosensory cortex (2mm posterior and 1.5mm lateral to bregma) or the barrel cortex (1.45mm posterior and 3mm lateral to bregma). To specifically target noradrenergic neurons, 0.3 µl of AAV9.rTH. Cre (G12845, Penn Vector Core) was injected into the LC (5.4mm posterior, 0.9mm lateral and 3.7mm ventral to bregma) of GiDREADD or tdTomato mice bred with Cx3cr1GFP. To express GqDREADD in noradrenergic neurons, we injected the following cocktail of three viruses into the LC of Cx3cr1 GFP/+ mice: AA9.rTH.PI.Cre, AAV9.DIO.hM3D(Gq) (44361, Addgene) and AAV9.FLEX.tdTomato (28306, Addgene).
Chronic window implantation.
Mice were implanted with a chronic cranial window as previously described 15 . Briefly, mice were anesthetized with isoflurane (3% induction, 1.2% maintenance) and maintained on a heating pad during surgery. A dental drill (Osada Model EXLM40) was used to drill a circular >3mm diameter craniotomy. For the limb/trunk region of the somatosensory cortex, the craniotomy center was approximately 2mm posterior and 1.5mm lateral to bregma. For the barrel cortex, the craniotomy center was approximately −1.45mm posterior and ±3mm lateral to bregma. A 3mm glass coverslip previously sterilized in 70% ethanol was placed inside the craniotomy, then light curing dental cement (Tetric EvoFlow) was applied around the glass coverslip and cured with a Kerr Demi Ultra LED Curing Light (Dental Health Products). The skull, excluding the region with the window, was then covered with IBond Total Etch glue (Heraeus) and cured with lightemitting diode light. Finally, a custom made head bar was attached to the skull using lightcuring dental glue. Mice were allowed to recover from anesthesia on a heating pad for 10 min before they were returned to their home cage. Ibuprofen in drinking water was provided as an analgesic for 48 h postsurgery.
In vivo two-photon imaging. After recovery from cranial window surgery (2-4 weeks), mice were trained to freely move on a custommade, rotating treadmill while head restrained ( Supplementary Fig. 1a ,b) for 3 days (2 sessions per day, 10 min per session). On the day of imaging, all mice with a clear, chronic glass window were included (approximately 50% of mice with attenuated window quality were excluded before any data collection). Mice were imaged using a two photon imaging system (Scientifica) equipped with a tunable Ti:Sapphire Mai Tai DeepSee laser (Spectra Physics). Laser wavelength was tuned to 900 nm to image Cx3cr1 GFP/+ microglia, 920 nm to image GCaMP6s fluorescence or 950 nm to image tdTomatolabeled LC projections. Imaging utilized a ×40 waterimmersion lens and a 180 × 180 μm field of view (512 × 512 pixel resolution). The microscope was equipped with a 565nm dichroic mirror and the following emission filters: 525/50 nm (green channel) and 620/60 nm (red channel) for GFP/tdTomato imaging and a 509nm dichroic mirror with 500/15 nm (green channel) and 537/26 nm (red channel) emission filters for GFP and yellow fluorescent protein (YFP) imaging. The laser power was maintained at 30-40 mW. Imaging in the cortex was conducted 50-150 μm beneath the pial surface. To induce general anesthesia in awake mice, isoflurane (3% for initiation, 1.2% for maintenance) was introduced through an anesthesia nose cone. Ketamine/xylazine (87.5 mg per kg ketamine, 12.5 mg per kg xylazine) and urethane (1.6 mg per kg) were administered through intraperitoneal injection. The body temperature of anesthetized mice was maintained at 37 °C by a heating pad. To image microglial dynamics, we acquired zstack images (8 sections, 2μm step size) once every minute ( Supplementary  Fig. 1c ). When selecting the zstack area, we focused on areas of the cortex in which approximately three microglial somas resided at a consistent zlevel and had processes that could be incorporated in the x-y imaging plane. The zstack range was then set so that microglial somas represented the approximate center of the zrange. All microglia preselected by these unbiased criteria were then analyzed. For calcium imaging, continuous acquisition (1Hz time series) was carried out approximately 60 μm from the pial surface to study neuronal process calcium activity in layer 1, or approximately 150 μm from the pial surface to study neuronal soma calcium activity in layer 2/3. For laser injury, we focused the laser at ×66magnification and held it at ∼250 mW for 1 s at an 800nm wavelength. For imaging microglia-neuron interactions, we used a GFP/YFP filter set and the same acquisition protocol as microglial surveillance studies. Data collection was not performed blinded to the conditions of the experiments.
Drug application in vivo. Intracerebral administration of neurotransmitters or antagonists was carried out through a catheter implanted 2 weeks after the chronic window implantation surgery (Fig. 3a, left panel) . The catheter was carefully placed in the subarachnoid space through the cisterna magna and close to the imaging window. We verified that dye can defuse through the catheter to the imaging window within seconds of infusion. The catheter was filled with ACSF to maintain patency, and no microglia activation was observed within the area of the window after implantation. A total volume of 10 µl of solution was applied through the catheter and into the brain. Neurotransmitters were exogenously applied at the following concentrations: 5 mM acetylcholine chloride, 1 mM dopamine hydrochloride, 3 mM NE and 5 mM serotonin hydrochloride. The dose of muscimol (870 µM) and TTX (10 µM) represents the minimal dose needed to induce significant suppression of neuronal activity. CNO was intraperitoneally injected at 5 mg per kg to activate GiDREADD in awake mice.
Imaging data analyses. Images were analyzed using ImageJ 51 . All microglia preselected via unbiased inclusion criteria were then analyzed. Inclusion criteria included a clearly identifiable soma near the center of the zstack and multiple processes incorporated within the x-y imaging plane. Because rapid movements by the animal could lead to image distortion in the x-y plane, five images were sequentially acquired at each zlevel ( Supplementary Fig. 1c ). At each zlevel, the user selected the image with the least distortion for inclusion in a 'sorted' zstack ( Supplementary Fig. 1d ). Images in this zstack were then aligned along the z axis using the StackReg plugin to create a final zstack used in analyses.
To obtain the total process area value, a maximumintensity projection (MIP) along the z axis was then created from the final zstack. After applying a uniform threshold to the MIP images, the Analyze particles tool was used to derive a process area value from this flattened image. To obtain a process surveillance territory value, a bounding box connecting the distalmost edges of the microglial processes was then mapped onto the MIP image. The area encompassed within this bounding box was defined as the microglial surveillance territory. Area and territory values in subsequent stacks were normalized to the values of the first stack to determine changes over time. Process velocity was measured using the Manual tracking plugin. Sholl analysis was performed in ImageJ with the Sholl analysis plugin. Zstacks acquired between the 10 and 20 min mark were used to evaluate microglial dynamics in the awake condition. Zstacks acquired between the 20 and 30 min mark after anesthesia (isoflurane, ketamine/xylazine and urethane) were used to evaluate microglial dynamics in the anesthetized conditions. Similarly, zstacks acquired between the 20 and 30 min mark were also used for analyses following all other manipulations: pharmacological, chemogenetic, optogenetic or sensory deprivation. For evaluating neuronal activity, calcium values above a set threshold (ΔF/F > 0.2) were summated in 1min bins and reported as the normalized change in sum relative to the first minute ( Fig. 1; Supplementary  Fig. 3 ). Alternatively, the same value was summated across a 10min period before and after either whisker trimming ( Supplementary Fig. 5a -c) or muscimol administration ( Supplementary Fig. 6 ).
To analyze interactions between microglial processes and neuronal dendrites, we calculated physical contact duration and the area of contact once per minute throughout a 30min recording in the awake animal. Under anesthesia conditions, we performed identical measurements between 30 and 60 min after anesthesia. Contact area between microglial processes and dendrites was normalized to the mean area of overlap determined during the first 10 min of recording in the awake condition. Data analysis was performed blinded to the conditions of the experiments.
Electrophysiology. For verification of ChR2 function in VGATpositive neurons or of GiDREADD function in noradrenergic neurons, we studied singlecell activity in transverse, acute brain slices (350 μm) containing either the somatosensory cortex (VGATChR2 mice) or the LC (Gi/GqDREADDexpressing mice). Transverse or sagittal brain slices were cut in chilled (2-4 °C) cutting solution containing the following (in mM): 185 sucrose, 2.5 KCl, 1.2 NaH 2 PO 4 , 25 NaHCO 3 , 25 glucose, 10 MgCl 2 and 0.5 CaCl 2 . Slices were then transferred to an incubator with ACSF containing the following (in mM): 130 NaCl, 2.5 KCl, 1.3 NaH 2 PO 4 , 26 NaHCO 3 , 10 glucose, 2 MgCl 2 , 2 CaCl 2 (pH 7.3-7.4; osmolarity: 300-310 mOsm; saturated with 95% O 2 /5% CO 2 to provide stable pH and continuous oxygenation). For recovery, slices were kept at 29-30 °C for a 30min period, then cooled and kept at room temperature for at least 1 h before recording. During recording, slices were continuously perfused with room temperature ACSF using a peristaltic bath perfusion system. Wholecell recordings were performed using glass pipettes (3-5 MΩ) filled with the following intracellular solution containing (in mM): 121 KCl, 19 potassiumgluconate, 5 NaCl, 4 MgCl 2 , 10 HEPES buffer, 0.1 EGTA, 4 MgATP, Na 2 GTP (pH 7.3-7.4; osmolarity: 280-290 mOsm). Data were collected using a MultiClamp 700B amplifier (Molecular Devices). Signals were filtered at 2 kHz and digitized at 10 kHz with a Digidata 1550 Data Acquisition System and analyzed using the software pCLAMP 10 (Molecular Devices) or Mini Analysis 6.0.3 (Synaptosoft).
For field potential recording in the somatosensory cortex in awake mice, a specialized recording headplate was adhered to the mouse 2 weeks before recording. Following 3 days of training on the treadmill platform, a craniotomy was made above the somatosensory cortex under general anesthesia, as described above, except that a smaller glass coverslip (2 mm in diameter) was affixed over part of the craniotomy to provide an unobstructed region for micropipette insertion and recording ( Supplementary Fig. 2e ). After recovery from the surgery, mice were headfixed and allowed to move on the treadmill. A glass pipettes filled with ACSF containing Alexa594 was inserted through the dura and into the cortex under twophoton guidance. Data were acquired continuously in the awake and anesthetized conditions using the parameters described above for singlecell recording.
Two-photon imaging of acute brain slices. Transverse brain slices were used for microglial imaging. Acute brain slices were prepared as described above in the "Electrophysiology" section. The imaging protocol was the same as described above for "In vivo twophoton imaging", except with modified imaging stack parameters (100-140 µm in depth, 2µm step size). Data analyses from slice imaging are the same as for the in vivo experiments. Drugs were applied in a bath. To prepare isofluraneenriched ACSF, carbogen gas was passed through an Anesthetic Vaporizer (Midmark Matrix, VIP 3000) at a constant flow rate of 500 ml min -1 and then bubbled through the ACSF reservoir.
RNAscope in situ hybridization and immunohistofluorescence staining. To visualize β 2 adrenergic receptor (Adrb2) mRNA in situ, a RNAscope 2.5 HD Detection kit (Advanced Cell Diagnostics, 322360) was applied in accordance with the manufacturer's protocol using fixed, frozen sections of 10µm thickness. Briefly, sections were first dried for 30 min at 60 °C and cleared of OCT embedding matrix via a 5min PBS wash. During pretreatment, the sections were incubated in hydrogen peroxide for 10 min at room temperature. Then the slides were submerged in 1× target retrieval solution for 5 min at 98-102 °C. After antigen retrieval, the slides were immediately transferred to distilled water and rinsed three to five times. Wash steps were then repeated with 100% ethanol. The sections were incubated in Protease Plus for protein digestion at 40 °C for 30 min. To run the assay, the RNAscope Probe MmAdrb2 (449771) was applied on pretreated sections for 120 min at 40 °C. After probe hybridization, the signal was amplified by incubation with amplifier 1-6 in sequence. Each incubation step was followed by two 2min washes using washing buffer. To visualize the hybridized signal, 2.5 HD Detection ReagentRED (322360) was applied onto the sections for 10 min at room temperature. The sections were rinsed in fresh tap water before observation. To further determine Adrb2 expression in microglia, the assay was continued with a modified immunofluorescence staining protocol following the manufacturer's instructions. Fluorescent images were acquired using a confocal microscope (Zeiss LSM810). Cells that were positive for IBA1 (Wako, 01919741, 1:500 dilution) and colocalized with two or more mRNA puncta were counted as positive.
Statistical analyses. Statistical analyses utilized a paired ttest design with a two tailed test of significance for changes within a cell across conditions. Comparisons between genotypes utilized an unpaired ttest design with a twotailed test of significance. D' Agostino-Pearson tests were used to assess normality before applying a parametric or nonparametric ttest variant (paired: Wilcoxon matched pairs rank test; unpaired: Mann-Whitney test). Oneway analysis of variance (ANOVA) was used to compare three groups. All statistical testing was performed using GraphPad Prism (GraphPad Software). Data distribution was assumed to be normal, but this was not formally tested. Data are shown as individual values or expressed as the mean ± s.e.m. when grouped. A P value < 0.05 was considered statistically significant. All P values that are not less than 0.0001 are provided as exact values, otherwise they are indicated as P < 0.0001. No statistical methods were used to predetermine sample sizes, but our sample sizes were similar to those reported in previous publications 13, 14 .
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